Data show hospitalized Covid-19 patients surviving at higher rates – STAT
Clinicians warn that the progress with treating Covid-19 won’t withstand what happens when crushes of patients again overwhelm hospitals.
Related Articles
Taking stock of the frenzied push into autoimmune disease
Check out the latest edition of Adam’s Biotech Scorecard, a new newsletter from @statnews.
Pharmalittle: We’re reading about BIO’s China challenge, Zepbound shortages, and more
BIO’s about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and…
23andme CEO Anne Wojcicki moves to take company private
After a tumultuous experience on the public markets, 23andMe CEO Anne Wojcicki is moving to take the company private.
Animal rights group urges SEC to investigate Charles River over monkey purchases
PETA has asked securities regulators to investigate Charles River Laboratories for allegedly misleading investors about its sales and purchases of long-tailed macaques.
ARCH, Medicines Co. veterans raise $290 million for in-licensed obesity drugs
After scouring 200 companies’ pipelines, a new biotech firm is launching with one of the most wide-ranging pipelines yet for obesity drug development.
Cancer vaccine startup launches with $54 million, Spark veteran as CEO
A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 million in funding.
Cerevel drug for Parkinson’s disease improved symptom control in trial
Cerevel Therapeutics, which AbbVie is acquiring, said Thursday its drug tavapadon, taken with the common Parkinson’s drug levodopa, showed positive results in controlling motor symptoms.
Medicaid should cover donor breast milk for vulnerable infants
Expanding Medicaid coverage of donor breast milk would save lives. Research shows it would also save taxpayers up to $60 million a year.
Microsoft is selling AI in health care, and helping to set its standards. Is that a problem?
For some, Microsoft’s deep involvement in setting standards for the use of AI in health care raises questions about “regulatory capture.”
How BIO CEO’s cozy relationship with WuXi soured
As lawmakers take aim at WuXi Apptec, the issue is testing the ability of BIO’s CEO to navigate a domestic policy issue that is tangled…